Compound tracker
Mescaline.
A source-backed research page for trial rows and update notes connected to this compound or investigational product. The page is generated from the Notion tracker and should be read as a living research map, not a medical conclusion.
2 trial rows 0 update rows Latest checked: Jan 24, 2024 All trials Claim boundary
Trial registration, company topline, CNPV/rolling-review status, recruitment status, public-dashboard data, or review literature do not equal approval, label, reimbursement, access, safety, or efficacy. Check each source note before turning a row into a claim.
Backlinks
This page links out to registry/source records, the global trial tracker, the updates feed, and matching wiki dossiers when available.
Trial rows
NCT04227756 Phase 1 Completed updated Jan 24, 2024
- Condition
- Healthy
- Sponsor / institution
- University Hospital, Basel, Switzerland
- Start date
- May 19, 2020
Tracker note / source boundary
ClinicalTrials.gov v2 sync on 2026-04-10 | Overall status: COMPLETED | Exact phase: Phase 1 | Lead sponsor: University Hospital, Basel, Switzerland | Conditions: Healthy
NCT04849013 Phase 1 Completed updated Mar 29, 2023
- Condition
- Healthy
- Sponsor / institution
- University Hospital, Basel, Switzerland
- Start date
- Aug 11, 2021
Tracker note / source boundary
ClinicalTrials.gov v2 sync on 2026-04-10 | Overall status: COMPLETED | Exact phase: Phase 1 | Lead sponsor: University Hospital, Basel, Switzerland | Conditions: Healthy
Related updates
No source-update rows are currently linked to this compound.
Conditions touched
Healthy